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The appropriate role for mechanical chest compression 
devices in pre-hospital care has been debated in 
recent years.1 The quality of manual cardiopulmonary 
resuscitation (CPR) during out-of-hospital cardiac 
arrest is often less than optimum, and aﬀ ects survival.2 
Mechanical compression devices are an attractive 
alternative: they never get tired, give consistent chest 
compressions, and allow CPR to continue during 
transfer of the patient. Results from two studies3,4 
of implementation of mechanical CPR devices in the 
so-called real world showed higher rates of return of 
spontaneous circulation and survival to discharge with 
mechanical CPR than with manual CPR. However, results 
from three randomised trials5–7 did not show signiﬁ cant 
survival beneﬁ t for mechanical CPR compared with 
manual CPR.
In The Lancet, Gavin Perkins and colleagues8 describe 
a pragmatic, cluster-randomised trial including adults 
with non-traumatic out-of-hospital cardiac arrest from 
four UK ambulance services. Ambulances were randomly 
assigned to either mechanical CPR (with the LUCAS-2 
device, ﬁ gure) or manual CPR. The investigators enrolled 
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fell in contrast to gains after most previous budgets.13 
Regular, rigorous, and structured advice to governments, 
especially ministries of ﬁ nance,  given by credible experts 
could help to triple excise tax and raise the price of the 
cheapest cigarettes. Global eﬀ orts have successfully 
used peer interventions to change the behaviour of sex 
workers;14 similar peer interventions could change the 
behaviour of ﬁ nance ministers. 
Eﬀ ective tobacco control over the next decade 
requires priority actions to increase excise taxes, 
while expanding coverage of plain packaging and 
bans on public smoking and on tobacco advertising, 
sponsorship, and promotion.1,3,5 Priority should also be 
given to strengthening research on tobacco use that 
is locally relevant—eg, by supporting the Richard Doll 
Centenary Classic Causes Consortium—since country-
speciﬁ c data can inform policy and generate vital 
political attention to tobacco control. Cancer Research 
UK will launch a global tobacco control research plan 
this year to generate new knowledge that can be used 
to support tobacco control measures. Focused actions 
could strengthen tobacco control worldwide and help 
to implement the FCTC more eﬀ ectively. If so, we could 
bring forward the time when many tens of millions of 
adult smokers quit and smoking uptake among young 
people falls, preventing millions of premature deaths.
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4471 patients (1652 patients in the LUCAS-2 group, 
and 2819 patients in the control group). However, 
only 985 (60%) patients in the mechanical CPR group 
actually received the LUCAS-2 intervention, as did 
11 (<1%) in the control group. 30 day survival (analysed 
by intention to treat) was similar for mechanical CPR 
(104 [6%] of 1652 patients) and manual CPR (193 [7%] 
of 2819 patients; adjusted OR 0·86, 95% CI 0·64–1·15). 
Neurological survival with favourable neurological 
outcome at 3 months was lower in the mechanical CPR 
group than in the manual CPR group (adjusted OR 0·72, 
95% CI 0·52–0·99).
The authors should be commended for attempting 
a real-world clinical trial on an important issue for 
Emergency Medical Services (EMS) systems worldwide. 
This study portrays the complexities and diﬃ  culties 
surrounding large-scale resuscitation trials, and the 
importance of attention to implementation and 
training in the assessment of any new technology. 
The somewhat low device usage rate (60%) reported 
in this study was due to diﬃ  culties in device use 
(15%), unknown reasons (6%), and non-compliance 
(16%). Even with apparent compliance, whether 
operational issues resulted in implementation delays 
with the mechanical device is unknown. The absence of 
diﬀ erence (or even inferiority) in outcomes in the trial 
group might not be due to the treatment or device itself, 
but to attention to training, compliance to protocols, 
and implementation.
When implementing a programme with a mechanical 
device that has weight and bulk, we cannot presume 
that ambulance crews would always carry the device 
with them when attending to a call. It would be relevant 
to know whether the LUCAS device was immediately 
started at the site or later, including in the ambulance. If 
later, substantial time delays in initiating mechanical CPR 
might have negated potential for beneﬁ t in device use.
The time from emergency call to arrival of the 
vehicle or ambulance crew at the patient’s side, as an 
indicator of duration of collapse before intervention 
by ambulance crew, might underestimate collapse 
intervals. This study8 did not calculate collapse time or 
collapse duration before application of interventions. 
Conventional therapies for cardiac arrest seem to have 
minimum eﬀ ect after long collapse intervals. Long 
intervals in the intervention group might conceal the 
eﬀ ect of these interventions. Assessment of the eﬀ ect 
of this collapse interval on outcomes after mechanical 
CPR might throw light on the relative usefulness of this 
mode of resuscitation.
About 60% of cardiac arrests attended were 
deemed not eligible and had no resuscitation 
attempted (6482 of 11 171). This proportion is rather 
high compared with that in many EMS systems 
internationally. This ﬁ nding raises questions of selective 
resuscitation by ambulance crews, although the study 
team did monitor for enrolment bias and noted no 
diﬀ erence between study groups.
Quality of implementation is an especially important 
issue with regard to the beneﬁ t or harm of mechanical 
CPR. Interruptions to CPR and delays in application of 
mechanical CPR devices are major factors that aﬀ ect 
outcomes.9 Wang and colleagues showed that human 
error and lack of training with mechanical CPR led to 
prolonged intervals without chest compression.10
Attention to team training and focusing on quality 
of deployment of mechanical CPR devices alone can 
greatly improve outcomes.11 The absence of quality 
implementation measures in this study,8 such as 
data on delays in application of the device or CPR 
interruptions, makes it diﬃ  cult to refute the hypothesis 
that the outcomes noted are possibly more an eﬀ ect of 
the quality of implementation rather than the therapy 
in question.
Although this study does not give us a deﬁ nitive 
answer to the debate between manual and mechanical 
CPR, it does throw a spotlight on implementation 
Figure: LUCAS-2 mechanical chest compression device
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Non-alcoholic steatohepatitis occurs when hepatic fat, 
inﬂ ammation, and liver-cell injury develop in insulin-
resistant individuals. Reports from US transplant 
registries show that non-alcoholic steatohepatitis 
is the third leading cause of end-stage liver disease,1 
and the second most common cause of primary liver 
cancer in patients listed for liver transplantation.2 
Yet no pharmacological therapy for non-alcoholic 
steatohepatitis is approved.
In The Lancet, Brent Neuschwander-Tetri and 
colleagues3 report on the eﬀ ects of obeticholic acid, 
a synthetic farnesoid X receptor agonist, in patients 
with non-alcoholic steatohepatitis, in a placebo-
controlled, randomised trial (FLINT). Patients were 
treated for 72 weeks and the primary endpoint was 
improvement in histology, as measured by a two-
point reduction in a composite activity histological 
score without worsening of ﬁ brosis. The therapeutic 
phase of the trial was stopped early partly because a 
preplanned interim analysis showed that more patients 
on obeticholic acid (50 [45%] of 110) than on placebo 
(23 [21%] of 109) reached the primary endpoint 
(relative risk 1·9, 95% CI 1·3–2·8). Unexpectedly, for 
a trial not powered to detect ﬁ brotic changes, the 
authors also reported an improvement in ﬁ brosis: 
36 (35%) of 102 obeticholic acid-treated patients 
regressed by one stage or more versus 19 (19%) of 
98 placebo-treated patients. Neither pioglitazone, a 
peroxisome proliferator-activated receptor-γ agonist, 
nor vitamin E signiﬁ cantly improved ﬁ brosis after 
2 years of treatment, despite similar reductions in non-
alcoholic fatty liver disease (NAFLD) activity score.4 
Starting the battle to control non-alcoholic steatohepatitis
and quality. EMS services should aim to provide the 
best quality of CPR possible. High-quality manual 
CPR requires EMS commitment to training and 
quality review. Mechanical CPR requires the same 
commitment to training and attention to deployment 
practices. Mechanical CPR is also more costly than 
manual CPR. EMS systems worldwide routinely 
transport patients with cardiac arrest to hospital with 
ongoing manual CPR of doubtful quality.12 Safety 
concerns for unrestrained crew using manual CPR in 
a moving ambulance are real. Mechanical CPR allows 
crews to be safely belted up and is a logical choice from 
the safety perspective.13
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